Dysregulation of lipids in Alzheimer’s disease and their role as potential biomarkers

A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES

Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429

Metabolite profiles and the risk of developing diabetes

Wang, T. J., Larson, M. G., Vasan, R. S., Cheng, S., Rhee, E. P., McCabe, E., Lewis, G. D., Fox, C. S., Jacques, P. F., Fernandez, C., et al. (2011) · Nature Medicine · doi:10.1038/nm.2307 · Cited by 3,143

Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics

Matyash, V., Liebisch, G., Kurzchalia, T. V., Shevchenko, A., & Schwudke, D. (2008) · Journal of Lipid Research · doi:10.1194/jlr.d700041-jlr200 · Cited by 2,633

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

Sreekumar, A., Poisson, L., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., et al. (2009) · Nature · doi:10.1038/nature07762 · Cited by 2,269

Update of the LIPID MAPS comprehensive classification system for lipids

Fahy, E., Subramaniam, S., Murphy, R. C., Nishijima, M., Raetz, C. R. H., Shimizu, T., Spener, F., van Meer, G., Wakelam, M. J. O., & Dennis, E. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r800095-jlr200 · Cited by 1,628

Ion Suppression in Mass Spectrometry

Annesley, T. M. (2003) · Clinical Chemistry · doi:10.1373/49.7.1041 · Cited by 1,598

Human ApoE isoforms differentially regulate brain amyloid-β peptide clearance

Castellano, J. M., Kim, J., Stewart, F. R., Jiang, H., DeMattos, R. B., Patterson, B. W., Fagan, A. M., Morris, J. C., Mawuenyega, K. G., Cruchaga, C., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002156 · Cited by 1,242

Shotgun lipidomics: Electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples

Han, X., & Gross, R. W. (2004) · Mass Spectrometry Reviews · doi:10.1002/mas.20023 · Cited by 1,126

Plasma phospholipids identify antecedent memory impairment in older adults

Mapstone, M. E., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3466 · Cited by 1,060

Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts

Ehehalt, R., Keller, P., Haass, C., Thiele, C., & Simons, K. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200207113 · Cited by 932

Lipidomics: coming to grips with lipid diversity

Shevchenko, A., & Simons, K. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2934 · Cited by 838

Apolipoprotein E ε4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease

Kivipelto, M., Helkala, E., Laakso, M. P., Hänninen, T., Hallikainen, M., Alhainen, K., Iivonen, S., Mannermaa, A., Tuomilehto, J., Nissinen, A. M., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-3-200208060-00006 · Cited by 642

Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry

Han, X., Holtzman, D. M., & McKeel, D. W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00332.x · Cited by 571

Identification of type 2 diabetes subgroups through topological analysis of patient similarity

Li, L., Cheng, W., Glicksberg, B. S., Gottesman, O., Tamler, R., Chen, R., Böttinger, E. P., & Dudley, J. T. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa9364 · Cited by 554

Differences between Human Plasma and Serum Metabolite Profiles

Yu, Z., Kastenmüller, G., He, Y., Belcredi, P., Möller, G., Prehn, C. P., Mendes, J., Wahl, S., Roemisch‐Margl, W., Ceglarek, U., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021230 · Cited by 523

Deregulation of sphingolipid metabolism in Alzheimer’s disease

He, X., Huang, Y., Li, B., Gong, C.-X., & Schuchman, E. H. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.010 · Cited by 516

Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics

Trushina, E., Dutta, T., Persson, X.-M. T., Mielke, M. M., & Petersen, R. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063644 · Cited by 438

Metabolomics in Early Alzheimer's Disease: Identification of Altered Plasma Sphingolipidome Using Shotgun Lipidomics

Han, X., Rozen, S., Boyle, S. H., Hellegers, C., Cheng, H., Burke, J. R., Welsh-Bohmer, K. A., Doraiswamy, P. M., & Kaddurah-Daouk, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021643 · Cited by 429

Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges

Füzéry, A. K., Levin, J. D., Chan, M. M., & Chan, D. W. (2013) · Clinical Proteomics · doi:10.1186/1559-0275-10-13 · Cited by 428

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium

Dieterle, F., Sistare, F. D., Goodsaid, F. M., Papaluca, M., Ozer, J. S., Webb, C. P., Baer, W., Senagore, A. J., Schipper, M. J., Vonderscher, J., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1625 · Cited by 410

Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicine

Drucker, E., & Krapfenbauer, K. (2013) · The EPMA Journal · doi:10.1186/1878-5085-4-7 · Cited by 360

Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease

Whiley, L., Sen, A., Heaton, J. C., Proitsi, P., García‐Gómez, D., Leung, R., Smith, N. W., Thambisetty, M., Kłoszewska, I., Mecocci, P., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.001 · Cited by 334

Sphingolipids and Cancer: Ceramide and Sphingosine-1-Phosphate in the Regulation of Cell Death and Drug Resistance

Ponnusamy, S., Meyers‐Needham, M., Senkal, C. E., Saddoughi, S. A., Sentelle, D., Selvam, S. P., Salas, A., & Öğretmen, B. (2010) · Future Oncology · doi:10.2217/fon.10.116 · Cited by 319

Efficacy of Souvenaid in Mild Alzheimer's Disease: Results from a Randomized, Controlled Trial

Scheltens, P., Twisk, J. W. R., Blesa, R., Scarpini, E. A., Arnim, C. A. F. V., Bongers, A., Harrison, J., Willemsen‐Swinkels, S. H. N., Stam, C. J., de Waal, H., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121189 · Cited by 314

Guidelines for the standardization of preanalytic variables for blood‐based biomarker studies in Alzheimer's disease research

O’Bryant, S. E., Gupta, V. B., Henriksen, K., Edwards, M., Jeromin, A., Lista, S., Bazenet, C. E., Soares, H. D., Lovestone, S., Hampel, H. J., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.08.099 · Cited by 294

Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production

Xiong, H., Callaghan, D., Jones, A., Walker, D. G., Lue, L., Beach, T. G., Sue, L. I., Woulfe, J., Xu, H., Stanimirovic, D. B., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.10.005 · Cited by 293

An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids

Surma, M. A., Herzog, R., Vasilj, A., Klose, C. D., Christinat, N., Morin‐Rivron, D., Simons, K., Masoodi, M., & Sampaio, J. L. (2015) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201500145 · Cited by 285

UPLC-ESI-QTOF/MS and multivariate data analysis for blood plasma and serum metabolomics: Effect of experimental artefacts and anticoagulant

Barri, T., & Dragsted, L. O. (2013) · Analytica Chimica Acta · doi:10.1016/j.aca.2013.01.015 · Cited by 278

SYMPOSIUM REVIEW: Lipid microdomains and the regulation of ion channel function

Dart, C. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.191585 · Cited by 273

Lipidomics: Analysis of the Lipid Composition of Cells and Subcellular Organelles by Electrospray Ionization Mass Spectrometry

Brügger, B. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035324 · Cited by 265

A comparison of five lipid extraction solvent systems for lipidomic studies of human LDL

Reis, A., Rudnitskaya, A. M., Blackburn, G. J., Fauzi, N. M., Pitt, A. R., & Spickett, C. M. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m034330 · Cited by 250

Targeted Metabolomics Identifies Reliable and Stable Metabolites in Human Serum and Plasma Samples

Breier, M., Wahl, S., Prehn, C. P., Fugmann, M., Ferrari, U., Weise, M., Banning, F., Seißler, J., Grallert, H., Adamski, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089728 · Cited by 240

Serum ceramides increase the risk of Alzheimer disease

Mielke, M. M., Bandaru, V. V. R., Haughey, N. J., Xia, J., Fried, L. P., Yaşar, S., Albert, M., Varma, V. R., Harris, G., Schneider, E. B., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318264e380 · Cited by 227

Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers

Dhingra, R., & Vasan, R. S. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.07.005 · Cited by 221

Phospholipids and Alzheimer’s Disease: Alterations, Mechanisms and Potential Biomarkers

Košiček, M., & Hecimovic, S. K. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14011310 · Cited by 220

An Efficient Single Phase Method for the Extraction of Plasma Lipids

Alshehry, Z. H., Barlow, C. K., Weir, J. M., Zhou, Y., McConville, M. J., & Meikle, P. J. (2015) · Metabolites · doi:10.3390/metabo5020389 · Cited by 219

Sex and ApoE Genotype Differences in Treatment Response to Two Doses of Intranasal Insulin in Adults with Mild Cognitive Impairment or Alzheimer's Disease

Claxton, A., Baker, L. D., Wilkinson, C. W., Trittschuh, E. H., Chapman, D., Watson, G. S., Cholerton, B., Plymate, S. R., Arbuckle, M., & Craft, S. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-122308 · Cited by 215

Plasma Apolipoprotein Levels Are Associated with Cognitive Status and Decline in a Community Cohort of Older Individuals

Song, F., Poljak, A., Crawford, J., Kochan, N. A., Wen, W., Cameron, B., Lux, O., Brodaty, H., Mather, K., Smythe, G. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034078 · Cited by 214

Soluble Aβ Oligomers Are Rapidly Sequestered from Brain ISF In Vivo and Bind GM1 Ganglioside on Cellular Membranes

Hong, S., Ostaszewski, B. L., Yang, T., O’Malley, T. T., Jin, M., Yanagisawa, K., Li, S., Bartels, T., & Selkoe, D. J. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.027 · Cited by 213

Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis

Proitsi, P., Kim, M. G., Whiley, L., Simmons, A., Sattlecker, M., Velayudhan, L., Lupton, M. K., Soininen, H., Kłoszewska, I., Mecocci, P., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.08.003 · Cited by 206

Ceramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell Death

Mullen, T. D., & Obeid, L. M. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012800228661 · Cited by 204

APOE2 enhances neuroprotection against Alzheimer’s disease through multiple molecular mechanisms

Conejero-Goldberg, C., Gomar, J. J., Bobes-Bascaran, T., Hyde, T. M., Kleinman, J. E., Herman, M. M., Chen, S., Davies, P., & Goldberg, T. E. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.194 · Cited by 199

Local cholesterol increase triggers amyloid precursor protein‐Bacel clustering in lipid rafts and rapid endocytosis

Marquer, C., Devauges, V., Cossec, J., Liot, G., Lécart, S., Saudou, F., Duyckaerts, C. J., Lévêque‐Fort, S., & Potier, M. (2011) · The FASEB Journal · doi:10.1096/fj.10-168633 · Cited by 196

Astroglial expression of ceramide in Alzheimer's disease brains: A role during neuronal apoptosis

Satoi, H., Tomimoto, H., Ohtani, R., Kitano, T., Kondo, T., Watanabe, M., Oka, N., Akiguchi, I., Furuya, S., Hirabayashi, Y., et al. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.056 · Cited by 196

Lipidomics: Potential role in risk prediction and therapeutic monitoring for diabetes and cardiovascular disease

Meikle, P. J., Wong, G., Barlow, C. K., & Kingwell, B. A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.001 · Cited by 189

Plasma and Serum Lipidomics of Healthy White Adults Shows Characteristic Profiles by Subjects’ Gender and Age

Ishikawa, M., Maekawa, K., Saito, K., Senoo, Y., Urata, M., Murayama, M., Tajima, Y., Kumagai, Y., & Saito, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091806 · Cited by 188

Mass Spectrometry Based Lipidomics: An Overview of Technological Platforms

Köfeler, H. C., Fauland, A., Rechberger, G. N., & Trötzmüller, M. (2012) · Metabolites · doi:10.3390/metabo2010019 · Cited by 187

Plasma biomarkers for mild cognitive impairment and Alzheimer's disease

Song, F., Poljak, A., Smythe, G. A., & Sachdev, P. S. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.05.003 · Cited by 181

Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer?s disease

Mulder, C., Wahlund, L., Teerlink, T., Blomberg, M. I., Veerhuis, R., van Kamp, G. J., Scheltens, P., & Scheffer, P. G. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0007-9 · Cited by 174

Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss

Mielke, M. M., Haughey, N. J., Bandaru, V. V. R., Schech, S., Carrick, R., Carlson, M. C., Mori, S., Miller, M. I., Ceritoglu, C., Brown, T., et al. (2010) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2010.03.014 · Cited by 170

Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions

Fabelo, N., Martín, M. V., Marín, R., Moreno, D., Ferrer, I., & Díaz, M. L. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.02.005 · Cited by 169

Plasma Biomarkers of Inflammation, the Kynurenine Pathway, and Risks of All-Cause, Cancer, and Cardiovascular Disease Mortality

Zuo, H., Ueland, P. M., Ulvik, A., Eussen, S. J. P. M., Vollset, S. E., Nygard, O. K., Midttun, Ø., Theofylaktopoulou, D., Meyer, K., & Tell, G. S. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kwv242 · Cited by 169

Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients

Walter, A., Korth, U., Hilgert, M., Hartmann, J., Weichel, O., Hilgert, M., Fassbender, K. C., Schmitt, A., & Klein, J. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.02.016 · Cited by 165

The association of urinary polycyclic aromatic hydrocarbon biomarkers and cardiovascular disease in the US population

Alshaarawy, O., Elbaz, H. A., & Andrew, M. E. (2016) · Environment International · doi:10.1016/j.envint.2016.02.006 · Cited by 162

Loss of the neuroprotective factor sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis

Couttas, T. A., Kain, N., Daniels, B., Lim, X. Y., Shepherd, C., Kril, J., Pickford, R., Li, H., Garner, B., & Don, A. S. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-9 · Cited by 161

Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals

Casanova, R., Varma, S., Simpson, B. N., Kim, M. G., An, Y., Saldana, S. J., Riveros, C., Moscato, P., Griswold, M. E., Sonntag, D., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.12.008 · Cited by 161

Plasma Sphingomyelins are Associated with Cognitive Progression in Alzheimer's Disease

Mielke, M. M., Haughey, N. J., Bandaru, V. V. R., Weinberg, D. D., Darby, E. J., Zaidi, N., Pavlik, V., Doody, R. S., & Lyketsos, C. G. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110405 · Cited by 158

Lipid changes in the aged brain: Effect on synaptic function and neuronal survival

Ledesma, M. D., Martín, M. G., & Dotti, C. G. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.11.004 · Cited by 154

Serum total cholesterol, statins and cognition in non-demented elderly

Solomon, A., Kåreholt, I., Ngandu, T., Wolozin, B., MacDonald, S. W. S., Winblad, B., Nissinen, A., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.09.012 · Cited by 149

Involvement of Sphingosine-1-Phosphate in Glutamate Secretion in Hippocampal Neurons

Kajimoto, T., Okada, T., Yu, H., Goparaju, S. K., Jahangeer, S. M., & Nakamura, S. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01465-06 · Cited by 148

ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brain

Bandaru, V. V. R., Troncoso, J. C., Wheeler, D., Pletniková, O., Wang, J., Conant, K., & Haughey, N. J. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.024 · Cited by 147

Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease

González‐Domínguez, R., García‐Barrera, T., & Gómez‐Ariza, J. L. (2014) · Journal of Proteomics · doi:10.1016/j.jprot.2014.01.014 · Cited by 144

Time-of-flight secondary ion mass spectrometry (TOF-SIMS) imaging reveals cholesterol overload in the cerebral cortex of Alzheimer disease patients

Lazar, A. N., Bich, C., Panchal, M., Desbenoît, N., Petit, V. W., Touboul, D., Dauphinot, L., Marquer, C., Laprévôte, O., Brunelle, A., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1041-1 · Cited by 141

The Reduction of Inflammatory Biomarkers by Statin, Fibrate, and Combination Therapy Among Diabetic Patients With Mixed Dyslipidemia

Muhlestein, J. B., May, H. T., Jensen, J. R., Horne, B. D., Lanman, R. B., Lavasani, F., Wolfert, R. L., Pearson, R. R., Yannicelli, H. D., & Anderson, J. L. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.009 · Cited by 140

Biochemical markers and the FDA Critical Path: How biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development

Karsdal, M. A., Henriksen, K., Leeming, D. J., Mitchell, P. G., Duffin, K. L., Barascuk, N., Klickstein, L. B., Aggarwal, P., Nemirovskiy, O. V., Byrjalsen, I., et al. (2009) · Biomarkers · doi:10.1080/13547500902777608 · Cited by 136

The Effect of Souvenaid on Functional Brain Network Organisation in Patients with Mild Alzheimer’s Disease: A Randomised Controlled Study

de Waal, H., Stam, C. J., Lansbergen, M. M., Wieggers, R. L., Kamphuis, P. J. G. H., Scheltens, P., Maestú, F., & van Straaten, E. C. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086558 · Cited by 120

Enrichment of cholesterol in microdissected Alzheimer’s disease senile plaques as assessed by mass spectrometry

Panchal, M., Loeper, J., Cossec, J., Perruchini, C., Lazar, A. N., Pompon, D., & Duyckaerts, C. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m001859 · Cited by 118

Cerebrospinal fluid sulfatide is decreased in subjects with incipient dementia

Han, X., Fagan, A. M., Cheng, H., Morris, J. C., Xiong, C., & Holtzman, D. M. (2003) · Annals of Neurology · doi:10.1002/ana.10618 · Cited by 113

The S-Connect study: results from a randomized, controlled trial of Souvenaid in mild-to-moderate Alzheimer's disease

Shah, R. C., Kamphuis, P. J., Leurgans, S., Swinkels, S. H., Sadowsky, C. H., Bongers, A., Rappaport, S. A., Quinn, J. F., Wieggers, R. L., Scheltens, P., et al. (2013) · Alzheimer's Research & Therapy · doi:10.1186/alzrt224 · Cited by 112

The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairment

Klavins, K., Koal, T., Dallmann, G., Marksteiner, J., Kemmler, G., & Humpel, C. (2015) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2015.05.003 · Cited by 111

Biomarker Discovery and Translation in Metabolomics

Gowda, G. N., & Raftery, D. (2013) · Current Metabolomics · doi:10.2174/2213235x113019990005 · Cited by 106

Cost-Effectiveness of Aspirin Treatment in the Primary Prevention of Cardiovascular Disease Events in Subgroups Based on Age, Gender, and Varying Cardiovascular Risk

Greving, J. P., Buskens, E., Koffijberg, H., & Algra, A. (2008) · Circulation · doi:10.1161/circulationaha.107.735340 · Cited by 103

Elevated cerebrospinal fluid sphingomyelin levels in prodromal Alzheimer's disease

Košiček, M., Zetterberg, H., Andreasen, N., Peter‐Katalinić, J., & Hecimovic, S. K. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.04.019 · Cited by 102

Relationship Between Biomarkers of Oxidized Low-Density Lipoprotein, Statin Therapy, Quantitative Coronary Angiography, and Atheroma Volume

Choi, S., Chae, A., Miller, E. R., Messig, M., Ntanios, F. Y., DeMaria, A. N., Nissen, S. E., Witztum, J. L., & Tsimikas, S. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.02.066 · Cited by 99

Optimizing the lipidomics workflow for clinical studies—practical considerations

Hyötyläinen, T., & Orešič, M. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-8633-2 · Cited by 94

GM1 ganglioside and Alzheimer’s disease

Yanagisawa, K. (2015) · Glycoconjugate Journal · doi:10.1007/s10719-015-9579-5 · Cited by 93

Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease

Bennett, S. A. L., Valenzuela, N., Xu, H., Franko, B., Fai, S., & Figeys, D. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00168 · Cited by 89

Cholesterol depletion reduces aggregation of amyloid-beta peptide in hippocampal neurons

Schneider, A., Schulz‐Schaeffer, W., Hartmann, T., Schulz, J. B., & Simons, M. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.015 · Cited by 86

Demographic and clinical variables affecting mid‐ to late‐life trajectories of plasma ceramide and dihydroceramide species

Mielke, M. M., Bandaru, V. V. R., Han, D., An, Y., Resnick, S. M., Ferrucci, L., & Haughey, N. J. (2015) · Aging Cell · doi:10.1111/acel.12369 · Cited by 85

Comparison of blood plasma sample preparation methods for combined LC–MS lipidomics and metabolomics

Patterson, R. E., Ducrocq, A. J., McDougall, D. J., Garrett, T. J., & Yost, R. A. (2015) · Journal of Chromatography B · doi:10.1016/j.jchromb.2015.08.018 · Cited by 80

Factors affecting longitudinal trajectories of plasma sphingomyelins: the Baltimore Longitudinal Study of Aging

Mielke, M. M., Bandaru, V. V. R., Han, D., An, Y., Resnick, S. M., Ferrucci, L., & Haughey, N. J. (2014) · Aging Cell · doi:10.1111/acel.12275 · Cited by 78

Healthy Lifestyle Characteristics and Their Joint Association With Cardiovascular Disease Biomarkers in US Adults

Loprinzi, P. D., Branscum, A. J., Hanks, J. E., & Smit, E. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.01.009 · Cited by 76

Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease

Mielke, M. M., Haughey, N. J., Bandaru, V. V. R., Zetterberg, H., Blennow, K., Andréasson, U., Johnson, S. C., Gleason, C. E., Blazel, H. M., Puglielli, L., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.019 · Cited by 70

Liquid Chromatography–Tandem Mass Spectrometry-Based Plasma Metabonomics Delineate the Effect of Metabolites’ Stability on Reliability of Potential Biomarkers

Yang, W. Q., Chen, Y., Xi, C., Zhang, R., Song, Y., Zhan, Q., Bi, X., & Abliz, Z. (2013) · Analytical Chemistry · doi:10.1021/ac303576b · Cited by 67

Plasma phospholipids and prevalence of mild cognitive impairment and/or dementia in the ARIC Neurocognitive Study (ARIC‐NCS)

Li, D., Misialek, J. R., Boerwinkle, E., Gottesman, R. F., Sharrett, A. R., Mosley, T. H., Coresh, J., Wruck, L. M., Knopman, D. S., & Alonso, Á. (2016) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2016.02.008 · Cited by 67

Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes

Lin, J., Hu, F. B., Mantzoros, C. S., & Curhan, G. C. (2009) · Diabetologia · doi:10.1007/s00125-009-1597-z · Cited by 63

Blood metabolite markers of cognitive performance and brain function in aging

Simpson, B. N., Kim, M. G., Chuang, Y., Beason‐Held, L. L., Kitner‐Triolo, M. H., Kraut, M. A., Lirette, S. T., Windham, B. G., Griswold, M. E., Legido‐Quigley, C., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15611678 · Cited by 63

A highly efficient, high-throughput lipidomics platform for the quantitative detection of eicosanoids in human whole blood

Song, J., Liu, X., Wu, J., Meehan, M. J., Blevitt, J. M., Dorrestein, P. C., & Milla, M. E. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.10.022 · Cited by 61

Targeted lipidomics distinguishes patient subgroups in mild cognitive impairment (MCI) and late onset Alzheimer's disease (LOAD)

Wood, P. L., Locke, V. A., Herling, P., Passaro, A., Vigna, G. B., Volpato, S., Valacchi, G., Cervellati, C., & Zuliani, G. (2015) · BBA Clinical · doi:10.1016/j.bbacli.2015.11.004 · Cited by 61

Discovering and validating between-subject variations in plasma lipids in healthy subjects

Begum, H., Li, B., Shui, G., Cazenave‐Gassiot, A., Soong, R. C. T., Ong, R. T., Little, P., Teo, Y., & Wenk, M. R. (2016) · Scientific Reports · doi:10.1038/srep19139 · Cited by 50

Plasma Phospholipid and Sphingolipid Alterations in Presenilin1 Mutation Carriers: A Pilot Study

Chatterjee, P., Lim, W. L. F., Shui, G., Gupta, V. B., JAMES, I. R., Fagan, A. M., Xiong, C., Sohrabi, H. R., Taddei, K., Brown, B. M., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150948 · Cited by 49

Neuronal β‐amyloid generation is independent of lipid raft association of β‐secretase BACE1: analysis with a palmitoylation‐deficient mutant

Motoki, K., Kume, H., Oda, A., Tamaoka, A., Hosaka, A., Kametani, F., & Araki, W. (2012) · Brain and Behavior · doi:10.1002/brb3.52 · Cited by 47

Is Urinary Sarcosine Useful to Identify Patients With Significant Prostate Cancer? The Trials and Tribulations of Biomarker Development

Schalken, J. A. (2010) · European Urology · doi:10.1016/j.eururo.2010.02.025 · Cited by 45

GM1 Ganglioside and the Seeding of Amyloid in Alzheimer’s Disease: Endogenous Seed for Alzheimer Amyloid

Yanagisawa, K. (2005) · The Neuroscientist · doi:10.1177/1073858405275177 · Cited by 45

Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heart disease: comparisons of single-/two-ventricle physiology, and systemic morphologically right/left ventricles

Miyamoto, K., Takeuchi, D., Inai, K., Shinohara, T., & Nakanishi, T. (2016) · Heart and Vessels · doi:10.1007/s00380-016-0807-0 · Cited by 44

Associations of Circulating Oxidized LDL and Conventional Biomarkers of Cardiovascular Disease in a Cross-Sectional Study of the Navajo Population

Harmon, M. E., Campen, M. J., Miller, C. P., Shuey, C., Cajero, M., Lucas, S., Pacheco, B., Erdei, E., Ramone, S., Nez, T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0143102 · Cited by 44

The Pathogenic Role of Ganglioside Metabolism in Alzheimer’s Disease-Cholinergic Neuron-Specific Gangliosides and Neurogenesis

Ariga, T. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9641-0 · Cited by 43

The APOE Genotype: Modification of Therapeutic Responses in Alzheimer's Disease

Hanson, A. J., Craft, S., & Banks, W. A. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666141020164222 · Cited by 42

Large-scaled human serum sphingolipid profiling by using reversed-phase liquid chromatography coupled with dynamic multiple reaction monitoring of mass spectrometry: Method development and application in hepatocellular carcinoma

Li, J., Hu, C., Zhao, X., Dai, W., Chen, S., Lu, X., & Xu, G. (2013) · Journal of Chromatography A · doi:10.1016/j.chroma.2013.10.064 · Cited by 41

Prediction of Cardiovascular Disease Risk by Cardiac Biomarkers in 2 United Kingdom Cohort Studies

Welsh, P. I., Hart, C., Papacosta, O., Preiss, D., McConnachie, A., Murray, H. M., Ramsay, S. E., Upton, M. N., Watt, G. C. M., Whincup, P. H., et al. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06501 · Cited by 40

Correlations of amyloid-β concentrations between CSF and plasma in acute Alzheimer mouse model

Cho, S. M., Kim, H. V., Lee, S., Kim, H. Y., Kim, W., Kim, T. S., Kim, D. J., & Kim, Y. S. (2014) · Scientific Reports · doi:10.1038/srep06777 · Cited by 39

A Nutritional Approach to Ameliorate Altered Phospholipid Metabolism in Alzheimer's Disease

Hartmann, T., van Wijk, N., Wurtman, R. J., Rikkert, M. G. M. O., Sijben, J., Soininen, H. S., Vellas, B. J., & Scheltens, P. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141137 · Cited by 35

The Influence of Sample Collection Methodology and Sample Preprocessing on The Blood Metabolic Profile

Jørgenrud, B., Jäntti, S. E., Mattila, I. M., Pöhö, P., Rnningen, K. S., Yki‐Järvinen, H., Orešič, M., & Hyötyläinen, T. (2015) · Bioanalysis · doi:10.4155/bio.15.16 · Cited by 35

Effects of rs769217 and rs1001179 polymorphisms of catalase gene on blood catalase, carbohydrate and lipid biomarkers in diabetes mellitus

Góth, L., Nagy, T., Kósa, Z., Fejes, Z., Bhattoa, H. P., Paragh, G., & Káplár, M. (2012) · Free Radical Research · doi:10.3109/10715762.2012.702899 · Cited by 35

The efficacy of supplementation with the novel medical food, Souvenaid, in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized clinical trials

Onakpoya, I., & Heneghan, C. J. (2015) · Nutritional Neuroscience · doi:10.1080/1028415x.2015.1110899 · Cited by 33

Commercialisation of Biomarker Tests for Mental Illnesses: Advances and Obstacles

Chan, M. K., Cooper, J. D., & Bahn, S. (2015) · Trends in biotechnology · doi:10.1016/j.tibtech.2015.09.010 · Cited by 28

Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study

Agarwala, A., Virani, S. S., Couper, D. J., Chambless, L. E., Boerwinkle, E., Astor, B. C., Hoogeveen, R. C., Coresh, J., Sharrett, A. R., Folsom, A. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.028 · Cited by 21

A Translational Medicine perspective of the development of torcetrapib: Does the failure of torcetrapib development cast a shadow on future development of lipid modifying agents, HDL elevation strategies or CETP as a viable molecular target for atherosclerosis? A case study of the use of biomarkers and Translational Medicine in atherosclerosis drug discovery and development

Zhao, L., Jin, W., Rader, D. J., Packard, C. J., & Feuerstein, G. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.014 · Cited by 17

Biomarkers to Improve the benefit/risk Balance for Approved Therapeutics: a US FDA Perspective on Personalized Medicine

Sapsford, K. E., Težak, Ž., Kondratovich, M., Pacanowski, M. A., Zineh, I., & Mansfield, E. A. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.62 · Cited by 16

Pharmacogenomic Biomarker Information in FDA ‐approved Paediatric Drug Labels

Kim, T., Han, N., Sohn, M., Oh, J. M., Lee, E., Ji, E., & Kim, I. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12341 · Cited by 10

Justifying reimbursement for Alzheimer's diagnostics and treatments: Seeking alignment on evidence

Foster, N. L., Hackett, J., White, G., Chenevert, S., Svarvar, P., Bain, L. J., & Carrillo, M. C. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.003 · Cited by 9

The significance of micro- and macrovascular biomarkers on cardiovascular outcome in chronic kidney disease: a prospective cohort study

Cseprekál, O., Egresits, J., Tabák, Á. G., Nemcsik, J., Járai, Z., Babos, L., Fodor, E., Farkas, K., Godina, G., Kárpáthi, K. I., et al. (2015) · Journal of Human Hypertension · doi:10.1038/jhh.2015.96 · Cited by 8

Integrating Biomarkers and Imaging for Cardiovascular Disease Risk Assessment in Diabetes

Tehrani, D. M., & Wong, N. D. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0789-7 · Cited by 7

Differential Changes in Regional Brain Ganglioside and Neutral Glycosphingolipid Contents in Alzheimer’s Disease

Kin, N. M. K. N. Y., Pan, L. H., Louvaris, J. H., Robitaille, Y., & Nair, N. P. V. (1995) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-1857-0_8 · Cited by 4

RE: Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval

Freidlin, B., & Korn, E. L. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv430 · Cited by 3

FDA and CLIA Oversight of Advanced Diagnostics and Biomarker Tests

Terry, S. F. (2010) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.1510 · Cited by 2

[Companion diagnostics and reimbursement system].

Tazawa, Y. (2013) · PubMed · Cited by 1

Integrated community-based diagnostics services: a critical success factor in value-based reimbursement.

Laughman, K. (2014) · PubMed · Cited by 1

Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies.

Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138

Alzheimer's Disease: Treatment Strategies and Their Limitations.

Passeri, E., Elkhoury, K., Morsink, M., Broersen, K., Linder, M., Tamayol, A., Malaplate, C., Yen, F. T., & Arab-Tehrany, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213954 · Cited by 689

Brain age and other bodily ‘ages’: implications for neuropsychiatry

Cole, J. H., Marioni, R. E., Harris, S. E., & Deary, I. J. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0098-1 · Cited by 450

Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies

Chew, H., Solomon, V. A., & Fonteh, A. N. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00598 · Cited by 353

Brain lipidomics: From functional landscape to clinical significance

Yoon, J. H., Seo, Y., Jo, Y. S., Lee, S., Cho, E., Cazenave-Gassiot, A., Shin, Y.-S., Moon, M. H., An, H. J., Wenk, M. R., et al. (2022) · Science Advances · doi:10.1126/sciadv.adc9317 · Cited by 324

Lipidomics of Alzheimer’s Disease

Touboul, D., & Gaudin, M. (2014) · Bioanalysis · doi:10.4155/bio.13.346 · Cited by 52

Lipids and Alzheimer’s Disease

Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485

Cerebrospinal fluid lipidomics for biomarkers of Alzheimer's disease

Byeon, S. K., Madugundu, A. K., Jain, A., Bhat, F. A., Jung, J. H., Renuse, S., Darrow, J. A., Bakker, A., Albert, M., Moghekar, A., et al. (2021) · Molecular Omics · doi:10.1039/d0mo00186d · Cited by 50

Lipidome disruption in Alzheimer’s disease brain: detection, pathological mechanisms, and therapeutic implications

He, S., Xu, Z., & Han, X. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00803-6 · Cited by 62

The application of lipidomics to biomarker research and pathomechanisms in Alzheimer's disease

Wong, M. W. K., Braidy, N., Poljak, A., & Sachdev, P. S. (2016) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000303 · Cited by 50